Biodesix BDSX 深 滬
已收盤 11-06 16:00:00 美东时间
8.53
-11.310
-57.01%
華盛通- 最 高13.04
- 今 開12.42
- 成交量 158.97万股
- 最 低 7.96
- 昨 收 19.84
- 總市值 9000.10万
- 52周最高 31.97
- 市盈率 靜 --
- 換手率 15.07%
- 52周最低 5.26
- 委 比 18.64%
- 總股本 1055.11万
- 歷史最高 639.80
- 量 比 15.41
- 振 幅 25.60%
- 歷史最低 3.436
- 每 手 1
- 風險率 6.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biodesix 2026财年第3季度营收净利双增长，净利润同比增长7.85%
Biodesix 最新财报显示，公司2026财年第3季度实现营业收入2404.1万美元，同比增长10.44%；净利润为-803.2万美元，同比增长7.85%。同...
今天 09:00
Biodesix收跌57.01%，成交额1544.53万美元
11月7日，Biodesix（BDSX）收跌57.01%，报8.53美元，成交额1544.53万美元，市值9000.1万美元。 行情数据 • 开盘价：12.4...
11-07 08:01
Biodesix Announces Departure of Chief Commercial Officer
An update from Biodesix ( ($BDSX) ) is now available. On November 2, 2026, Biod...
11-06 05:59
Biodesix shares are trading lower after the company reported worse-than-expected Q3 sales results and lowered its FY2026 sales guidance below estimates.
Biodesix shares are trading lower after the company reported worse-than-expected Q3 sales results and lowered its FY2026 sales guidance below estimates.
11-06 05:53
Biodesix Lowers FY2026 Sales Guidance from $108.000M-$114.000M to $101.000M-$103.000M vs $111.817M Est
Biodesix (NASDAQ:BDSX) lowers FY2026 sales outlook from $108.000 million-$114.000 million to $101.000 million-$103.000 million vs $111.817 million estimate.
11-06 05:03
Biodesix to Participate in Upcoming Investor Conferences
Biodesix, Inc. announced that its leadership team will participate in two upcoming investor conferences: the UBS Global Healthcare Conference on November 10 in Palm Beach Gardens, FL, and the Craig-Hallum Alpha Select Conference on November 17 in New York, NY. The events will include fireside chats and one-on-one meetings, with a live webcast available on Biodesix's website. Biodesix is a diagnostics solutions company focused on improving patient...
11-04 11:00
Biodesix收跌5.93%，成交额157.21万美元
10月31日，Biodesix（BDSX）收跌5.93%，报23.25美元，成交额157.21万美元，市值2.45亿美元。 行情数据 • 开盘价：25.06美元...
10-31 06:32
Biodesix收涨0.04%，成交额337.85万美元
10月23日，Biodesix（BDSX）收涨0.04%，报23.94美元，成交额337.85万美元，市值2.53亿美元。 行情数据 • 开盘价：23.76美元...
10-23 06:34
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
Biodesix, Inc. (Nasdaq: BDSX) announced it will release its third-quarter 2026 financial results on November 5 after market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Listeners can register via the provided links, with a replay available later. Biodesix is a diagnostic solutions company focused on improving patient outcomes through advanced testing and developmen...
10-22 10:00
